Bellevue Medical Center founded in July 2009, is a general hospital located in Mansourieh, Lebanon. It offers healthcare services in many specialties. The hospital has a capacity of 130 beds within its eight floors.

There are 130 beds in Bellevue Medical Center.

During the past decade, Bellevue Medical Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bellevue Medical Center" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Arafat Tfayli" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored and "Janssen Research & Development, LLC" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bellevue Medical Center" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator and "Phoenix Clinical Research" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Bellevue Medical Center" are "Carcinoma, Non-Small-Cell Lung" (1 trials), "Colorectal Cancer" (1 trials), "Crohn's Disease" (1 trials), "HER2-Positive Early Breast Cancer" (1 trials) and "Multiple Sclerosis (MS)" (1 trials). Many other conditions were trialed in "Bellevue Medical Center" in a lesser frequency.

Most popular intervention types in "Bellevue Medical Center" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Compound 121564" (1 trials), "Data Collection" (1 trials), "Guselkumab" (1 trials) and "Guselkumab Dose 1" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bellevue Medical Center" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Bellevue Medical Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Bellevue Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bellevue Medical Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".